A dual-action GLP-1/GIP program for patients whose clinician recommends a two-pathway approach
Thus, DPP4 inhibition also plays an important role irrespective of the duration of diabetes
Cengage Learning
Current FDA labels document these patterns in detail: Wegovy (semaglutide) lists nausea (44% vs 16% placebo), vomiting (25% vs 6%), diarrhea (30% vs 16%), constipation (24% vs 11%), abdominal distension and eructation, with severe GI events in 4.1% versus 0.9% placebo.[2] Zepbound (tirzepatide) lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, eructation, and gastroesophageal reflux disease among common adverse reactions, with severe GI disease as a Warnings and Precautions item.[3] Both labels include postmarketing reports of ileus, severe constipation including fecal impaction, and acute kidney injury related to dehydration from severe GI symptoms
1) Though berberine may contribute to a small amount of weight loss for some people, studies are limited and often include people who were making other dietary and lifestyle changes at the same time
Antioxidants are particularly beneficial because when the thyroid is overproducing and overworking youre going to have more oxidants formed, youre going to have more oxidative stress
